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Nowadays, in low mortality countries, increases in life expect-
ancy are often taken for granted. Life expectancy has risen since
the eighteenth century in some European countries, including
England, France and Scandinavia.1–3 In The Netherlands,
mortality reductions are likely to have started in the nineteenth
century.2 From 1840/51 to 1990/94 life expectancy increased
from 36.1 to 74.2 years in men and from 38.5 to 80.2 years in
women.4
This impressive increase in length of life has been
accompanied by substantial changes in the age-at-death and
cause-of-death patterns. Changes in the cause-of-death pattern
from mainly infectious diseases to chronic diseases were
accompanied by a shift in the age pattern of mortality from
younger ages to older ages.5 Since the early 1970s, declines in
mortality from chronic diseases at older ages have caused sharp
rises in life expectancy of the elderly population.5–7 Uncertainty
abounds as to whether the decline in mortality at older ages will
continue to generate substantial increases in life expectancy.
Two opinions are prevalent. One group of researchers, known
as the proponents of ‘the limited-lifespan paradigm’, believes
that average life expectancy will not increase beyond 85 years
of age.8–10 Further substantial reductions in death rates at ad-
vanced ages are constrained by biological barriers (e.g. senescence)
and/or by societal barriers (e.g. environmental deterioration).
The increasingly rectangular shape of the survival curve, seen as
a manifestation of the fact that the natural limit to human life
has almost been completed,9 and the enormous reductions 
in mortality rates which would be needed to achieve a life
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expectancy at birth of 85 years10 are used as arguments in
support of this view.
Others, known as proponents of ‘the mortality-reduction
paradigm’,11–15 argue that the decline in mortality rates will
continue and may even accelerate, including also the most
advanced ages. A life expectancy at birth of 100 years or more
is considered to be within reach somewhere in the near
future.12,13 The observed decrease in mortality at advanced
ages of 1–2% per year, and the very low mortality rates in
subpopulations with healthy life styles, are used as arguments
in favour of substantial future increases in life expectancy.11,13
Several studies have reported rapid declines in oldest-old
mortality.7,11,16–18 In the Netherlands, too, a country with
traditionally low mortality and reliable mortality data at
advanced ages,19 life expectancy of the elderly (65+) and the
oldest old (85+) has increased.20 This study aims at obtaining a
better understanding at the recent changes in mortality in the
Dutch elderly population. The central questions are: (1) did the
increase in life expectancy of the elderly population accelerate,
continue or stagnate in past years and (2) which age- and cause-
specific mortality dynamics underlay these recent changes in the
life expectancy? We will use total and cause-specific Dutch
mortality data of the population aged >60 in 1970/74–1990/94.
Methods
Data
Data on the population and the number of deaths by age, sex
and underlying cause of death for 1970–1994 were obtained
from Statistics Netherlands.21,22 Total mortality and population
data had originally been derived from municipal population
registers and can be considered reliable and consistent. Popu-
lation and total mortality data by single year-of-age were used,
whereas cause-specific mortality data were only available by 
5-year age groups, with age >95 as the oldest age group. In
1970–1994 causes of death were classified according to two
different revisions of the International Classification of Diseases,
Injuries and Causes of Death: the Eighth Revision (ICD-8) for
1970–1978 and the Ninth Revision (ICD-9) for 1979–1994. In
order to maximize the comparability over both ICD classi-
fications, we regrouped the causes classified in both revisions
into 26 cause-of-death groups (Appendix 1).
Methods
We started with a description of the change in life expectancy at
age 60 and age 85 in The Netherlands in 1970/74–1990/94. Life
expectancies were estimated from complete life tables with 
age 105 as oldest age group. These life tables, each covering 
five calendar years, were constructed for both sexes from total
mortality and population data, using standard demographic
techniques.23,24
Next, we looked for explanations of the change in life ex-
pectancy at age 60 and 85 in the 1970s (1970/74–1980/84) and
the 1980s (1980/84–1990/94) by examining the contribution 
of different age groups and causes of death to the change in 
life expectancy. This contribution was estimated from age- 
and cause-specific mortality data using a method developed by
Arriaga,25,26 which decomposes the change in life expectancy
into the contribution to this change of different age groups and/
or causes of death. Although changes in age and cause-specific
mortality rates also give an indication of the contribution of
different ages and causes to the change in life expectancy, we
prefer the Arriaga method for two reasons. First, this method
takes into account substitution between competing causes of
death. Second, it takes into account the fact that similar changes
in mortality rates at different ages influence life expectancy—
being a population health measure—to a different extent. The
magnitude of the effect of (changes in) age- and cause-specific
mortality rates on life expectancy is weighted (1) by the size of
the life-table population in a certain age group exposed to the
(changed) rate, and (2) the remaining life expectancy of that
age group. Due to this implicit weighting in the life table,
changes in mortality rates that are not important for the health
of the population, for instance because the population at risk
being exposed to these rates is rather small, are not weighted
heavily. In general, changes at young ages have a larger impact
on life expectancy than changes at advanced ages.27,28 This 
is due to the fact that (1) only a small proportion of the popu-
lation is exposed to changes in mortality rates at advanced ages,
as not everyone survives up to these ages and (2) the remaining
life expectancy at older ages is much smaller, reflecting the high
risks of mortality at older ages. It merits attention that life
expectancy (and thus changes in life expectancy) is unaffected
by the age distribution of the actual population, which enables
comparisons to be made over time and between groups (e.g. by
sex). The age distribution of the life-table population is only
determined by the mortality rates.
Notwithstanding the favourable properties of life table based
methods like the Arriaga method, examining changes in age-
and cause-specific mortality rates is useful as well. Having
assessed which age groups and causes of death contributed most
to the change in life expectancy, looking at changes in age- and
cause-specific rates will provide more insight into the exact
changes. Therefore we also calculated directly standardized
death rates (using the population of 1990/94 by 5-year of age
up to age 95+ as standard) for each 5-year period. We expressed
changes in standardized mortality rates as ratios of comparative
mortality figures (CMF). To assess whether these changes in the
ratios of CMF were statistically significant, we calculated 95%
CI of the CMF ratios.29 In the presentation of the outcomes of
the age-specific changes in total mortality, we focus on the
change in CMF by 10-year age groups since 1970/74. Results 
for specific cause-of-death groups are not shown separately in
Tables or Figures. Only cause-specific changes in mortality are
presented separately for the age group 85+ in the 1980s, because
changes in mortality in the oldest old have been striking since
1980/84 in The Netherlands30 and deserve a closer inspection.
Results
Change in life expectancy
During the past two decades, life expectancy of the elderly and
oldest-old population has increased in The Netherlands. Table 1
shows that life expectancy at age 60 increased from 16.95 to
18.22 years in men and from 20.87 to 23.14 years in women 
in the period 1970/74–1990/94. Life expectancy at age 85
increased from 4.46 to 4.63 years in men and from 4.96 to 5.82
years in women in the same period. A closer inspection of Table 1
indicates that the gain in life expectancy was not evenly spread
across the different 5-year periods. In men, the increase in life
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expectancy at age 60 was slightly larger in the 1980s (0.7 years)
than in the previous decade (0.6 years), whereas in women the
opposite was true (1970s 1.8 years; 1980s 0.4 years). The trend
in life expectancy at age 85 was even more remarkable: a gain
was seen until 1980/84 (men) and 1985/89 (women), but since
then life expectancy at age 85 has declined.
Contribution of different age groups and causes
of death to the change in life expectancy
Because changes in age- and cause-specific mortality might give
clues to changes in the determinants of mortality, we first
assessed the extent to which mortality declines or increases in
different age groups and cause-of-death groups contributed to
the described change in life expectancy.
Table 2 shows the contribution of different age groups to the
change in life expectancy at ages 60 and 85 calculated with 
the Arriaga method. A ‘positive’ contribution indicates that a
mortality reduction in the relevant age group contributes to an
increase in life expectancy, whereas a ‘negative’ contribution
indicates that a mortality increase contributes to a reduction of
life expectancy. In the 1970s mortality reductions in all age
groups contributed to the increase in life expectancy at age 60
and age 85, although the size of these contributions differed.
The most striking development in the 1980s was that mortality
changes at age >85 (men) and at age >90 (women) contributed
negatively to the increase in life expectancy at age 60. At age 85,
the same changes in mortality were responsible for the
stagnating increase in life expectancy among women (–0.02
years) and for the decline in life expectancy among men (–0.22
years). That life expectancy at age 60 continued to increase was
due to mortality reductions in the age groups between 60 and
84 years of age, which have a larger impact on life expectancy
at age 60. For men, larger mortality declines at ages 65–79
produced an even larger increase in life expectancy at age 60 in
the 1980s, despite the unfavourable developments at older ages.
For women the increase in life expectancy at age 60 was smaller
than in the 1970s because the positive impact of mortality
reductions below age 90 also shrank.
The contributions of the five causes of death which contri-
buted most, both in a positive and negative sense, to the change
in life expectancy at age 60 and age 85 in the 1970s and 1980s
are presented in Tables 3a, 3b. Table 3b shows that in the 1980s
mortality increases from chronic obstructive pulmonary disease
(COPD), mental disorders and diabetes mellitus (and to a lesser
extent other cancers [men] and lung cancer [women]) contri-
buted ‘negatively’ to the increase in life expectancy at age 60.
Mortality increases from these diseases, together with those
from prostate cancer (men) and ill-defined conditions (women),
were also largely responsible for the decline (men) and plateau
(women) in life expectancy at age 85 in this period. At age 60,
these effects were counterbalanced by mortality reductions from,
in particular, ischaemic heart disease (IHD) and cerebrovascular
diseases, and from lung cancer (men) and other heart diseases
(women). However, at age 85, the negative effect of mortality
increases outweighed the positive effect of mortality reductions
from other causes.
Compared to the 1980s, the 1970s had shown both larger
positive contributions (1970s: 0.64 [men] and 1.03 [women]
versus 1980s: 0.27 [men] and 0.37 [women]) and smaller
negative contributions (1970s: –0.25 [men] and –0.15 [women]
versus 1980s: –0.48 [men] and –0.39 [women]) to the life
expectancy at age 85, which on balance produced the increase
in life expectancy at age 85 in the 1970s, and the decrease
(men) or stagnation (women) in the 1980s (Tables 3a,3b). Both
smaller mortality reductions (or sometimes even an increase 
in mortality) from cerebrovascular diseases and other cardio-
vascular diseases—which contributed largely to the increase in
life expectancy at age 85 in the 1970s—and (larger) mortality
increases from e.g. COPD, mental disorders and diabetes
mellitus, together with those from cancer (prostate and other
cancers) and ill-defined conditions, explain the reversal of the
trend in life expectancy at age 85.
Changes in age- and cause-specific mortality
Figure 1 shows the ratios of the standardized mortality rates
(CMF) by 10-year age groups since 1970/74, using 1970/74 
Table 1 Life expectancy at age 60 and age 85, The Netherlands, by sex
Men Women
At age At age At age At age
60 years 85 years 60 years 85 years
1970/74 16.95 4.46 20.87 4.96
1975/79 17.15 4.74 21.89 5.45
1980/84 17.52 4.85 22.72 5.84
1985/89 17.78 4.74 23.01 5.86
1990/94 18.22 4.63 23.14 5.82
Table 2 Decomposition of the change in life expectancy at age 60 and
age 85 in 1970/74–1980/84 and 1980/84–1990/94, The Netherlands,
by sexa
Men Women
At age At age At age At age
60 years 85 years 60 years 85 years
1970/74–1980/84
60–64 +0.20 – +0.14 –
65–69 +0.17 – +0.25 –
70–74 +0.07 – +0.38 –
75–79 +0.03 – +0.41 –
80–84 +0.03 – +0.37 –
85–89 +0.04 +0.20 +0.20 +0.59
90–94 +0.02 +0.12 +0.07 +0.22
95+ +0.01 +0.07 +0.02 +0.07
Total +0.58 +0.39 +1.85 +0.88
1980/84–1990/94
60–64 +0.22 – +0.02 –
65–69 +0.23 – +0.05 –
70–74 +0.18 – +0.10 –
75–79 +0.10 – +0.16 –
80–84 +0.01 – +0.11 –
85–90 –0.02 –0.08 +0.03 +0.07
90–94 –0.02 –0.08 –0.02 –0.05
95+ –0.01 –0.05 –0.02 –0.05
Total +0.70 –0.22 +0.42 –0.02
a Figures are rounded to 0.01.
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as reference (i.e. 1970/74 = 1). The developments in the 1970s
and 1980s in mortality for each age group are clear at a glance.
Whereas in the 1970s, mortality rates in all age groups
decreased, in the 1980s only mortality rates in the age groups
60–69 and 70–79 continued to decline. In the age groups 80–89
mortality rates stagnated (women) or increased slightly, but 
not significantly (men). Above 90+ a significant increase was
observed in both men and women in the 1980s. As could be
expected, the age groups which showed a mortality increase or
a decline, are the same as those picked out by means of the
Arriaga method. However, comparison of Figure 1 and Table 2
makes it clear that caution should be exercised when looking at
changes in mortality rates in order to explain changes in life
expectancy. For example, Figure 1 shows that the reduction in
the CMF for age group 90+ was largest for men in the 1970s,
whereas Table 2 shows that this age group did not contribute
most to the increase in life expectancy at age 60. After all, the
contribution of age group 70–79 (0.1) was higher than that of
90+ (0.03).
Table 4 focuses on recent changes in mortality rates above 
age 85 from specific causes. For the ease of interpretation, we
expressed the change as the ratio of the CMF in 1990/94 to that
in 1980/84 (i.e. 1980/84 = 1). A ratio larger than 1 indicates an
increase in mortality as compared to 1980/84, whereas a ratio
smaller than 1 indicates a decline. Some causes of death showed
mortality declines in the 1980s, but overall the situation was
one of mortality increase. Significant increases in mortality
above age 85 from mental disorders, diabetes mellitus and other
endocrine, nutritional and metabolic diseases, COPD, diseases of
the nervous system, diseases of blood and blood-forming organs,
ill-defined conditions, prostate and other cancers, infectious/
parasitic diseases and pneumonia/influenza took place. These
Table 3a Decomposition of the contribution of selected causes of death to the change in life expectancy at age 60 and 85 in 1970/74–1980/84,
The Netherlands, by sexa
Men Women
At age 60 years
All causes +0.577 All causes +1.847
Increase in life expectancy +0.961 Increase in life expectancy +1.915
Ischaemic heart disease +0.257 Cerebrovascular diseases +0.417
Cerebrovascular diseases +0.197 Ischaemic heart disease +0.391
Pneumonia/influenza +0.091 Other cardiovascular disease +0.186
Stomach cancer +0.083 Pneumonia/influenza +0.137
Traffic accidents +0.065 Other heart diseases +0.134
Restb +0.268 Restb +0.650
Decrease in life expectancy –0.384 Decrease in life expectancy –0.068
Lung cancer –0.177 Lung cancer –0.040
Other heart diseases –0.079 Other causes –0.014
Other cancers –0.052 Breast cancer –0.006
Prostate cancer –0.022 Diseases of nervous system –0.006
Chronic obstructive pulmonary disease –0.017 Other endocrine –0.002
Restb –0.038 Restb –0.000
At age 85 years
All causes +0.387 All causes +0.878
Increase in life expectancy +0.641 Increase in life expectancy +1.031
Other cardiovascular diseases +0.133 Ischaemic heart disease +0.193
Cerebrovascular diseases +0.129 Cerebrovascular diseases +0.182
Ischaemic heart disease +0.119 Other cardiovascular diseases +0.180
Ill-defined conditions +0.078 Other accidents +0.110
Pneumonia/influenza +0.066 Ill-defined conditions +0.101
Restb +0.116 Restb +0.265
Decrease in life expectancy –0.254 Decrease in life expectancy –0.153
Lung cancer –0.054 Genito-urinary –0.048
Chronic obstructive pulmonary disease –0.050 Diseases of digestive system –0.031
Other heart diseases –0.037 Other causes –0.026
Diseases of digestive system –0.028 Other endocrine –0.021
Diseases of nervous system –0.017 Diseases of nervous system –0.014
Restb –0.068 Restb –0.013
a Figures are rounded to 0.001.
b Available from authors on request.
causes also contributed in a negative sense to the decline (men)
and plateau (women) in life expectancy at age 85 (Tables 3a, 3b).
Discussion
This study examined recent mortality changes in the elderly
population of The Netherlands in the 1970s and in the 1980s.
Our results showed that life expectancy at age 60 increased 
in the 1970s and 1980s, whereas life expectancy at age 85 has
declined since 1980/84 (men) and 1985/89 (women). Constant
mortality rates in women at ages 85–89, and an increase in
mortality rates above age 85 (men) and above age 90 (women)
underlay this trend in life expectancy at age 85. Decomposition
of the change in life expectancy by cause of death showed that
both smaller mortality reductions (or sometimes even an
increase in mortality) from cerebrovascular diseases and other
cardiovascular diseases—which contributed largely to the in-
crease in life expectancy at age 85 in the 1970s—and mortality
increases from e.g. COPD, mental disorders and diabetes mellitus,
together with those from cancer (prostate and other cancers)
and ill-defined conditions produced the decrease (men) and
plateau (women) in life expectancy at age 85. The continuing
rise in life expectancy at age 60, on the other hand, was caused
by mortality reductions at ages 60–84 which have a relatively
large impact on life expectancy at age 60.
Before turning to the meaning and implications of our results,
it must be emphasized that the findings, which are based on
underlying cause-of-death data, might be subject to coding and
classification errors. First, at advanced ages, underlying causes
of death are difficult to assess and may therefore be unreliable.31
Furthermore, estimates of the magnitude of the effects of IHD
and other heart diseases might be biased, due to the ICD
Revision of 1979. The number of deaths from these causes by
calendar year showed a small increase for other heart diseases
mirrored by a decrease for IHD between 1978 and 1979. Finally,
the effect of diabetes mellitus and mental disorders might be
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Table 3b Decomposition of the contribution of selected causes of death to the change in life expectancy at ages 60 and 85 in 1980/84–1990/94,
The Netherlands, by sexa
Men Women
At age 60 years
All causes +0.701 All causes +0.423
Increase in life expectancy +1.131 Increase in life expectancy +0.996
Ischaemic heart disease +0.596 Ischaemic heart disease +0.442
Lung cancer +0.144 Cerebrovascular diseases +0.186
Cerebrovascular diseases +0.132 Other heart diseases +0.137
Stomach cancer +0.072 Stomach cancer +0.054
Genito-urinary +0.048 Other accidents +0.047
Restb +0.138 Restb +0.130
Decrease in life expectancy –0.430 Decrease in life expectancy –0.573
COPD –0.079 Mental disorders –0.131
Diabetes Mellitus –0.078 Diabetes Mellitus –0.120
Other cancers –0.065 Chronic obstructive pulmonary disease –0.098
Mental disorders –0.053 Lung cancer –0.085
Other cardiovascular diseases –0.039 Diseases of the nervous system –0.022
Restb –0.117 Restb –0.118
At age 85 years
All causes –0.215 All causes –0.022
Increase in life expectancy +0.266 Increase in life expectancy +0.371
Ischaemic heart disease +0.091 Ischaemic heart disease +0.118
Other heart diseases +0.081 Other heart diseases +0.110
Genito-urinary +0.046 Other accidents +0.042
Cerebrovascular diseases +0.018 Cerebrovascular diseases +0.028
Stomach cancer +0.016 Stomach cancer +0.021
Restb +0.014 Restb +0.053
Decrease in life expectancy –0.481 Decrease in life expectancy –0.393
Chronic obstructive pulmonary disease –0.102 Mental disorders –0.152
Mental disorders –0.064 Diabetes mellitus –0.062
Prostate cancer –0.047 Ill-defined conditions –0.036
Other cancers –0.044 Chronic obstructive pulmonary disease –0.031
Diabetes mellitus –0.039 Other endocrine –0.023
Restb –0.184 Restb –0.089
a Figures are rounded to 0.001.
b Available from authors on request.
LIFE EXPECTANCY AT ADVANCED AGE 145
overestimated due to a more frequent classification of diabetes
mellitus32 and senile dementia (part of mental disorders; per-
sonal communication Statistics Netherlands) as underlying
cause of death in The Netherlands since 1983 and 1992, re-
spectively. The number of deaths from diabetes by calendar year
showed an increase in diabetes deaths in the years immediately
after 1982. For senile dementia the increase started before 
and continued after the change in classification. Despite these
uncertainties related to cause-of-death data, our findings
indicating a lack of improvement in life expectancy at advanced
ages are based on Dutch total mortality rates. Total mortality
rates in The Netherlands are considered to be very reliable even
Figure 1a Comparative Mortality Figure (CMF) by 5-year period as a ratio of the CMF in 1970/74 by
10-year age group, The Netherlands, men
Figure 1b Comparative Mortality Figure (CMF) by 5-year period as a ratio of the CMF in 1970/74 by
10-year age group, The Netherlands, women
for the oldest-old age groups,19 because mortality and popu-
lation data are derived from municipal population registers that
have been kept in The Netherlands since 1850.22 At birth a
personal card based on the birth certificate is made and all
changes in vital status, including death, are recorded on this
card. This guarantees a high validity of age recording and since
population registers not only provide data on mortality, but also
on the population at risk by single year of age and sex, a single
source is used to estimate mortality rates, which avoids biases.
Moreover, differences in the contribution of each age group
to the change in life expectancy (based on the Arriaga method)
and changes in age-specific mortality rates (based on the CMF
method) merit attention. The outcomes of both methods might
not always lead to the same conclusion. Comparison of the con-
tribution of different age groups to the change in life expectancy
(Arriaga) and the standardizd mortality rates (CMF) by 10-year
age groups shows that although the direction of the effect is the
same, its relative importance can differ. For a full understanding
of the changes in mortality, information derived from both
approaches is needed. To explain changes in life expectancy,
which was the primary focus of this paper, the Arriaga method
is the most appropriate of the two, because, like life expectancy,
it takes into account the fact that changes in mortality in
different age groups affect life expectancy to a different extent.
The magnitude of the effect depends upon the size of the popu-
lation in a certain age group being exposed to the (changed) mor-
tality rate and the remaining life expectancy of this age group.
On the other hand, changes in age-specific mortality rates
provide more insight into changes in the age structure and size
of the elderly population. In addition, looking at changes in age-
and cause-specific mortality rates is indispensable to discovering
possible determinants of the changes in mortality.
Studies for other low mortality countries have found no rises
in mortality in the oldest old.6,11,18 Only in Norway did mor-
tality at advanced ages increase slightly between 1986/90 and
1991/94.33 Explanations for the recent rise in old-age mortality
in The Netherlands (and Norway) are still being sought. More
research on this topic is needed. As a start, we will elaborate on
possible explanations for the recent rise in old-age mortality 
in The Netherlands. First, the increase in old-age mortality
might have been caused by excess mortality due to influenza
epidemics in 1989/90 and 1993.34,35 This is not likely, however.
In 1975 and 1978, influenza also produced substantial excess
mortality34 without seriously interrupting the mortality decline
among the oldest old. In addition, our results are not very
sensitive to annual perturbations due to influenza epidemics,
for we used quinquennial data. Second, the alleged liberalization
of euthanasia policy could have brought forward the average
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Table 4 Ratio of comparative mortality figurea (CMF) of 1990/94 to CMF of 1980/84 at age >85, by sex
Men 95% CI Women 95% CI
Infectious + parasitic diseases 1.63 1.38–1.93 1.51 1.33–1.71
Stomach cancer 0.77 0.70–0.85 0.67 0.62–0.73
Colorectal cancer 0.96 0.88–1.04 0.91 0.86–0.96
Lung cancer 1.21 1.14–1.29 0.97 0.84–1.11
Breast cancer 0.74 0.32–1.71 1.05 0.98–1.12
Prostate cancer 1.34 1.26–1.42 – –
Other cancers 1.20 1.15–1.26 1.06 1.03–1.10
Diabetes Mellitus 2.22 1.98–2.49 1.98 1.85–2.12
Endocr. + Nutritional 1.52 1.30–1.77 1.71 1.55–1.88
Blood + blood forming 1.88 1.56–2.27 1.56 1.36–1.80
Mental disorders 4.88 4.22–5.64 4.93 4.54–5.35
Nervous system 1.52 1.36–1.70 1.48 1.35–1.62
Ischaemic heart disease 0.85 0.83–0.88 0.83 0.81–0.85
Cerebrovascular diseases 0.96 0.93–1.00 0.97 0.94–0.99
Other cardiovascular diseases 1.14 1.07–1.22 0.91 0.86–0.95
Other heart diseases 0.86 0.84–0.89 0.87 0.85–0.89
Pneumonia/influenza 1.15 1.09–1.20 1.06 1.02–1.10
Chronic obstructive pulmonary disease 1.52 1.45–1.60 1.39 1.31–1.48
Other respiratory 1.17 1.01–1.35 1.04 0.91–1.18
Digestive system 1.06 0.99–1.13 1.03 0.99–1.07
Genito-urinary 0.75 0.71–0.80 0.89 0.85–0.93
Ill-defined 1.28 1.20–1.35 1.20 1.15–1.25
Traffic accidents 0.72 0.56–0.93 0.86 0.57–1.30
Other accidents 0.95 0.88–1.03 0.77 0.73–0.81
Other external causes 0.87 0.71–1.07 0.65 0.51–0.84
Other causes 1.32 1.15–1.51 1.19 1.11–1.27
Total 1.06 1.05–1.08 1.02 1.01–1.03
a CMF using the 1990/94 population as standard population.
– Not applicable.
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age at death. However, considering the low frequency of physician
assistance in death at advanced ages (only 1.8% [1.3–2.5%] 
of all deaths above age 80) and the estimated small decrease in
the length of life due to euthanasia (less than one week in 76%
of these cases),36 we do not consider euthanasia a significant
factor. Third, the increase in mortality from (lung) cancer and
COPD among the oldest old suggests that (past) smoking behav-
iour might have contributed to the increase in mortality. A
reconstruction of smoking prevalence by birth cohort37 showed
that the percentage of (ex)smokers in men aged >85 was prob-
ably higher in 1990/94 than in 1980/84. However, although
past smoking behaviour might have played a role, the evidence
is not conclusive. After all, this factor cannot explain the increase
in female mortality at advanced ages, as the percentage of (ex)-
smokers aged >85 was too small to have had a significant effect
on old-age mortality.
The causes discussed so far cannot fully explain the increase
in mortality at advanced ages and thus we should consider
other causes, such as those relating to changes in the distri-
bution of morbidity and frailty in the population. Less selection
due to decreased mortality may have produced a frailer oldest-
old population.38 The subsequent increase in mortality from
mental disorders, ill-defined conditions and influenza/pneumonia
might be a manifestation of this increased frailty. In addition,
decreased mortality from circulatory diseases might have created
a pool of people with circulatory diseases, who run a higher risk
of developing severe stages of these diseases and dying from
them.39,40 Finally, reduced mortality from circulatory diseases
might have increased the prevalence of diseases that share the
same risk factors or are themselves a risk factor for circulatory
diseases, such as some cancers or diabetes mellitus. Although it
is plausible that these factors have contributed to the increase in
old-age mortality, it is not clear why these mechanisms, which
may be expected to operate in other countries as well, have not
(yet) caused old-age mortality to rise in these countries.
Further investigation into the determinants of the old-age
mortality is necessary and may benefit from empirical data on
the current developments in old-age mortality in The Nether-
lands and other low mortality countries. Monitoring of old-age
mortality and cross-national comparisons should therefore
receive high priority. In addition, an important, but in terms 
of data requirements very demanding step, would be to disen-
tangle the changes in incidence, disease progression, and fatality
of chronic diseases which have caused the mortality increases in
the oldest old in The Netherlands.
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Appendix 1 Classification in cause-of-death groups according to the International Classification of Disease 
ICD-8 ICD-9
Name of disease category ICD-Chapter 1970–1978 1979–
Infectious and parasitic diseases 1 001–136 001–139
Cancer of stomach 2 151 151
Cancer of colorectum 2 153–154 153–154
Cancer of trachea, bronchus and lung 2 162–163 162–163;165
Cancer of breast 2 174 174–175
Cancer of prostate 2 185 185
Other neoplasms 2 r(140–239) r(140–239)
Diabetes mellitus 3 250 250
Other endocrine, nutritional and metabolic diseases 3 240–246;251–269;270–279 240–246;251–259;260–279
Diseases of blood and bloodforming organs 4 280–289 280–289
Mental disorders 5 290–315 290–319
Diseases of the nervous system and sense organs 6 320–389 320–389
Ischaemic heart diseases 7 410–414 410–414
Cerebrovascular diseases 7 430–438 430–438
Other cardiovascular diseases 7 440–448;450–458 440–448;415;417;451–459
Other heart diseases 7 390–398;400–404;420–429 390–398;401–405;416;420–429
Pneumonia/influenza 8 470–474;480–484;486 487;480–486
Chronic obstructive pulmonary disease 8 490–493 490–494;496
Other diseases of the respiratory system 8 r(460–519) r(460–519);495
Diseases of the digestive system 9 520–577 520–579
Diseases of the genito-urinary system 10 580–629 580–629
Symptoms and ill-defined conditions 16 780–796 780–799
Traffic accidents 17 E800–845;E940–941 E800-E848
Other accidents 17 E880–887;E890–909; E880–888;E890–909;
E911–929;E943–946;E980–989 E911–929;E980–989
Other external causes 17 E850–877; E850–869;E910;
E910; E930–999 E870–879;
excl. E940–941 excl. E943–946 E930–999;
excl. E980–989 excl. E980–989
Other causes 11–15 630–678; 630–676;
680–686;690–709;710–738; 680–686;690–709;710–739;
740–759; 740–759;
760–776 760–779
